VU661013
Product Specifications
CAS Number
2131184-57-9
SKU
C13646-5mg
Target
Bcl-2
Applications
Apoptosis
Smiles
CC1CN (C (=O) C2=C (C3=C (N12) C (=C (C=C3) Cl) C4=C (N (N=C4C) C) C) CCCOC5=CC (=C (C (=C5) C) Cl) C) C6=CN (C7=C6C=C (C=C7) C (=O) O) C
Molecular Formula
C39H39Cl2N5O4
Additionnal Information
VU661013 is a novel, potent, selective MCL1 inhibitor with Ki of 97 ± 30 pM of human MCL-1 in a TR-FRET assay. However, VU661013 does not significantly inhibit BCL-xL or BCL-2 with Ki > 40 μM or = 0.73 μM. VU661013 de-stabilizes BIM/MCL-1 association, leads to apoptosis in AML.
Storage Conditions
3 years -20°C powder
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
S1013-57E2-AP 100 µL
Siglec 1 (Sialic Acid Binding Ig-like Lectin 1, CD169, CD169 Antigen, dJ1009E24.1, DKFZp667F058, FLJ00051, FLJ00055, FLJ00073, FLJ00411, FLJ32150, Sialic Acid-binding Ig-like Lectin 1, Sialic Acid-binding Ig-like Lectin-1, Sialoadhesin, Sialoadhesin Precursor, Siglec 1, SN) (AP) discontinued
Ask
View Details 
MBS1113172-01 0.05 mg (E-Coli)
Recombinant Streptococcus equi subsp. zooepidemicus UPF0346 protein Sez_1447 (Sez_1447)
Ask
View Details MBS1113172-02 0.2 mg (E-Coli)
Recombinant Streptococcus equi subsp. zooepidemicus UPF0346 protein Sez_1447 (Sez_1447)
Ask
View Details